Physician profile
Drew Stal
NPI 1376962530
$3,110.94
in general payments reported to CMS, 2019-2025
13 companies · $138 in 2025
The $138 reported for 2025 was less than what a typical Foot and Ankle Surgery provider received nationally (typical 2025 total: $1,200).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $942 · 2021: $1,073 · 2023: $60.24 · 2024: $898 · 2025: $138.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,066 · Education: $30.75.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,065.50 |
| Education | $30.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,638.10 | 2020-2023 | Infinity Adaptis |
| Pylant Medical | $540.01 | 2020-2024 | |
| Restor3d, INC. | $207.43 | 2024 | |
| Exactech, INC. | $153.94 | 2021 | |
| Medshape, INC. | $149.68 | 2024 | Dynanail |
| Acumed LLC | $147.48 | 2021 | |
| Smith+Nephew, INC. | $103.01 | 2024-2025 | Pico 7, Q-Fix, Footprint |
| Globus Medical, INC. | $37.89 | 2025 | Autobahn, Anthem |
| Lifenet Health | $36.06 | 2024 | Theragenesis Wound Matrix |
| Kerecis Limited | $29.49 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Polynovo North America LLC | $25.98 | 2025 | Novosorb Btm |
| Orthofix Medical, INC. | $25.68 | 2024 | Accelstim, Physio-Stim |
| Zimmer Biomet Holdings, INC. | $16.19 | 2024 | Gps III Platelet Concentration System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Drew Stal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.